Search Results - "TARTE, K"

High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trial by Rossille, D, Gressier, M, Damotte, D, Maucort-Boulch, D, Pangault, C, Semana, G, Le Gouill, S, Haioun, C, Tarte, K, Lamy, T, Milpied, N, Fest, T

“…The dosage of soluble programmed cell death ligand 1 (sPD-L1) protein in the blood of adults with cancer has never been performed in a prospective patient…”
Get full text

IL-6 supports the generation of human long-lived plasma cells in combination with either APRIL or stromal cell-soluble factors by Jourdan, M, Cren, M, Robert, N, Bolloré, K, Fest, T, Duperray, C, Guilloton, F, Hose, D, Tarte, K, Klein, B

“…The recent understanding of plasma cell (PC) biology has been obtained mainly from murine models. The current concept is that plasmablasts home to the BM and…”
Get full text

High rate of TNFRSF14 gene alterations related to 1p36 region in de novo follicular lymphoma and impact on prognosis by Launay, E, Pangault, C, Bertrand, P, Jardin, F, Lamy, T, Tilly, H, Tarte, K, Bastard, C, Fest, T

“…Follicular lymphoma (FL) is characterized by the balanced chromosomal translocation t(14;18)(q32;q21) in about 80-90% of the cases. This primary event is not…”
Get full text

Follicular lymphoma cell niche: identification of a preeminent IL-4-dependent TFH–B cell axis by Pangault, C, Amé-Thomas, P, Ruminy, P, Rossille, D, Caron, G, Baia, M, De Vos, J, Roussel, M, Monvoisin, C, Lamy, T, Tilly, H, Gaulard, P, Tarte, K, Fest, T

“…Follicular lymphoma (FL) B cells contract tight connections with their microenvironment, which governs the pathogenesis and progression of the disease. Indeed,…”
Get full text

Unique B Cell Differentiation Profile in Tolerant Kidney Transplant Patients by Chesneau, M., Pallier, A., Braza, F., Lacombe, G., Le Gallou, S., Baron, D., Giral, M., Danger, R., Guerif, P., Aubert‐Wastiaux, H., Néel, A., Michel, L., Laplaud, D.‐A., Degauque, N., Soulillou, J.‐P., Tarte, K., Brouard, S.

“…Operationally tolerant patients (TOL) display a higher number of blood B cells and transcriptional B cell signature. As they rarely develop an allo‐immune…”
Get full text

Characterization of intratumoral follicular helper T cells in follicular lymphoma: role in the survival of malignant B cells by Amé-Thomas, P, Le Priol, J, Yssel, H, Caron, G, Pangault, C, Jean, R, Martin, N, Marafioti, T, Gaulard, P, Lamy, T, Fest, T, Semana, G, Tarte, K

“…Accumulating evidences indicate that the cellular and molecular microenvironment of follicular lymphoma (FL) has a key role in both lymphomagenesis and patient…”
Get full text

Soluble programmed death-ligand 1 as a prognostic biomarker for overall survival in patients with diffuse large B-cell lymphoma: a replication study and combined analysis of 508 patients by Rossille, D, Azzaoui, I, Feldman, A L, Maurer, M J, Labouré, G, Parrens, M, Pangault, C, Habermann, T M, Ansell, S M, Link, B K, Tarte, K, Witzig, T E, Lamy, T, Slager, S L, Roussel, M, Milpied, N, Cerhan, J R, Fest, T

Get full text

Adipose mesenchymal stromal cells: Definition, immunomodulatory properties, mechanical isolation and interest for plastic surgery by Bertheuil, N., Chaput, B., Ménard, C., Varin, A., Laloze, J., Watier, E., Tarte, K.

“…Ever since their discovery in 2001, adipose mesenchymal stromal cells (ASC) have profoundly modified clinical indications and our practice of plastic surgery,…”
Get full text

BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone by Moreaux, Jérôme, Legouffe, Eric, Jourdan, Eric, Quittet, Philippe, Rème, Thierry, Lugagne, Cécile, Moine, Philippe, Rossi, Jean-François, Klein, Bernard, Tarte, Karin

“…Identification of growth factors in neoplasias may be a target for future therapies by blocking either growth factor receptor interaction or the induced…”
Get full text

Monocytes and T cells cooperate to favor normal and follicular lymphoma B-cell growth: role of IL-15 and CD40L signaling by Epron, G, Ame-Thomas, P, Le Priol, J, Pangault, C, Dulong, J, Lamy, T, Fest, T, Tarte, K

“…Interleukin-15 (IL-15) has been extensively studied for its role in the survival and proliferation of NK and T cells through a unique mechanism of…”
Get full text

AXICABTAGENE CILOLEUCEL AS SECOND‐LINE THERAPY FOR LARGE B‐CELL LYMPHOMA IN TRANSPLANT‐INELIGIBLE PATIENTS: FINAL ANALYSIS OF ALYCANTE, A PHASE 2 LYSA STUDY by Houot, R., Bachy, E., Cartron, G., Gros, F., Morschhauser, F., Oberic, L., Gastinne, T., Feugier, P., Dulery, R., Thieblemont, C., Joris, M., Jardin, F., Choquet, S., Casasnovas, O., Brisou, G., Cheminant, M., Bay, J., Gutierrez, F. Llamas, Menard, C., Tarte, K., Delfau, M., Itti, E., Bailly, C., Al Tabaa, Y., Laurent, C., Lemonnier, F.

Get full text

ATEZOLIZUMAB + OBINUTUZUMAB + VENETOCLAX IN PATIENTS WITH RELAPSED OR REFRACTORY MARGINAL ZONE LYMPHOMA: PRIMARY ANALYSIS OF A PHASE 2 TRIAL FROM LYSA by Herbaux, C., Schiano de Colella, J. M., Thieblemont, C., Guidez, S., Ysebaert, L., Tilly, H., Le Gouill, S., Houot, R., Bachy, E., Laurent, C., Damaj, G., Feugier, P., Morineau, N., Tarte, K., Morschhauser, F., Cartron, G.

Get full text

ATEZOLIZUMAB + OBINUTUZUMAB + VENETOCLAX IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA: PRIMARY ANALYSIS OF A PHASE 2 TRIAL FROM LYSA by Cartron, G., Bachy, E., Guidez, S., Gyan, E., Gressin, R., Morineau, N., Sibon, D., Casasnovas, O., Le Gouill, S., Tilly, H., Ysebaert, L., Schiano de Colella, J. M., Feugier, P., Virelizier, E. Nicolas, Haioun, C., Damaj, G., Tarte, K., Laurent, C., Houot, R., Thieblemont, C., Morschhauser, F., Herbaux, C.

Get full text

ING1b negatively regulates HIF1α protein levels in adipose-derived stromal cells by a SUMOylation-dependent mechanism by Bigot, N, Guérillon, C, Loisel, S, Bertheuil, N, Sensebé, L, Tarte, K, Pedeux, R

“…Hypoxic niches help maintain mesenchymal stromal cell properties, and their amplification under hypoxia sustains their immature state. However, how MSCs…”
Get full text

Adipose-derived stromal cells: history, isolation, immunomodulatory properties and clinical perspectives by Bertheuil, N, Chaput, B, Ménard, C, Varin, A, Garrido, I, Grolleau, J L, Sensébé, L, Watier, E, Tarte, K

“…Over the last decade, the clinical use of adipose-derived stromal/stem cells (ASC) in regenerative medicine is rapidly increasing. ASC belong to the…”
Get full text

Immunological characterization of multipotent mesenchymal stromal cells. the international society for cellular therapy (ISCT) working proposal by Krampera, M, Galipeau, J, Shi, Y, Tarte, K, Sensebe, L

Get full text

P1133: SUB‐CUTANEOUS RITUXIMAB INDUCTION FOLLOWED BY SHORT RITUXIMAB MAINTENANCE IMPROVES PFS IN PATIENTS WITH LOW‐TUMOR BURDEN FOLLICULAR LYMPHOMA. FINAL RESULTS OF FLIRT PHASE III TRIAL, A LYSA STUDY by Cartron, G., Bachy, E., Tilly, H., Daguindau, N., Pica, G.‐M., Bijou, F., Mounier, C., Clavert, A. M., Damaj, G. L., Slama, B., Casasnovas, O., Houot, R., Bouabdallah, K., Sibon, D., Fitoussi, O., Morineau, N., Herbaux, C., Gastinne, T., Fornecker, L.‐M., Haioun, C., Launay, V., Araujo, C., Benbrahim, O., Sanhes, L., Gressin, R., Gonzalez, H., Morschhauser, F., Xerri, L., Tarte, K., Pranger, D.

Get full text

P890 SPECIFIC PHENOTYPE AND GENE EXPRESSION PROFILES OF COMBINED LIVER AND KIDNEY TRANSPLANTED PATIENTS IN PERIPHERAL BLOOD MONONUCLEAR CELLS by Dumontet, E, Danger, R, Vagefi, P, Londoño, M.-C, Pallier, A, Lozano, J.J, Giral, M, Degauque, N, Martínez-Llordella, M, Latournerie, M, Boudjéma, K, Dulong, J, Tarte, K, Soulillou, J.-P, Sanchez-Fueyo, A, Feng, S, Brouard, S, Conchon, S

Get full text

Dendritic cell-based vaccine : a promising approach for cancer immunotherapy by TARTE, K, KLEIN, B

“…The unique ability of dendritic cells to pick up antigens and to activate naive and memory CD4+ and CD8+ T cells raised the possibility of using them to…”
Get full text

Culture and characterization of mesenchymal stem cells in a totally defined medium by Gadelorge, M, Mariono, V. Vidal, Dulong, J, Descamps, J, Caillot, L, Conway, C, Tarte, K, Sensebe, L

Get full text